Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Mutares in connection with the acquisition of Allianceplus Sweden
Mandate

Vinge advises Mutares in connection with the acquisition of Allianceplus Sweden

November 09, 2021 Employment and Benefits M&A EU, Competition and Regulatory

Vinge advises the German private equity firm Mutares SE & Co. KGaA in connection with the acquisition of Allianceplus Sweden (“Allianceplus”) from Allianceplus Holding A/S, a portfolio company of Polaris Private Equity.

Allianceplus is engaged in the business of soft facility management. The company is headquartered in Stockholm and offers its services across Sweden with primary focus on Stockholm, Gothenburg, and Malmö. Allianceplus generated approx. EUR 27 million and employed over 500 people in 2020.

Mutares SE & Co. KGaA, a listed private equity holding company with offices in Munich (HQ), Frankfurt, London, Madrid, Milan, Paris, Stockholm and Vienna, acquires small- and medium-sized companies and parts of groups in special situations with headquarters in Europe that show significant potential for operational improvement and are sold again after undergoing a repositioning and stabilization process.

Vinge’s team consisted of Karl Klackenberg and Christina Kokko (M&A), Lisa Hörnqvist (Commercial agreements), Ebba Svenburg (Employment) together with Sebastian Örndahl and Jesper Ekman (Merger filing).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025